Mankind Pharma Limited
MANKIND
Classement en actions
#2064
Mankind Pharma Limited specializes in the development, manufacturing, and... Mankind Pharma Limited specializes in the development, manufacturing, and marketing of a broad range of pharmaceutical medications and consumer health goods. Operating predominantly in India, the company also caters to international markets. Its pharmaceutical division focuses on both acute and chronic therapeutic areas, encompassing a wide spectrum of medical conditions such as infectious diseases, cardiovascular ailments, gastrointestinal disorders, diabetes, dermatology, pain management, neuro/CNS issues, nutritional support (vitamins/minerals), and respiratory problems. Complementing its pharmaceutical portfolio, the consumer healthcare segment offers diverse products, including condoms, pregnancy detection kits, emergency contraceptives, antacid powders, vitamin and mineral supplements, and anti-acne preparations. Key brands under its umbrella include Manforce, Prega News, Unwanted-72, Gas-O-Fas, Health OK, and AcneStar. Furthermore, the company's business activities are diversified, extending to the trading and export of pharmaceutical and healthcare products, as well as the manufacturing of various goods such as packaging materials, ayurvedic products, bulk drugs, and general consumer items. Mankind Pharma also holds interests in real estate, leasing, hospitality, and IT services. Established in 1986, Mankind Pharma Limited maintains its headquarters in New Delhi, India.
Prix de l'action
$24.08
Capitalisation boursière
$9.95B
Changement (1 jour)
-4.09%
Changement (1 an)
-13.33%
Pays
IN
Échange Mankind Pharma Limited (MANKIND)
Catégorie
Healthcare
Ratio P/B pour Mankind Pharma Limited (MANKIND)
Ratio P/B au 2026 TTM : 0
Selon les derniers rapports financiers et le cours de l'action de Mankind Pharma Limited, le ratio cours/valeur comptable actuel (TTM) est 0. À la fin de 2026, le ratio P/B était de 0.
Historique du ratio P/B pour Mankind Pharma Limited de 2019 à 2026
Ratio P/B à la fin de chaque année
| Année | Ratio P/B | Changez |
|---|---|---|
| 2025 | 6.94 | -29.83% |
| 2024 | 9.89 | 29.08% |
| 2023 | 7.66 | -17.22% |
| 2022 | 9.26 | -23.28% |
| 2021 | 12.07 | -26.19% |
| 2020 | 16.35 | -19.00% |
| 2019 | 20.18 | 0.00% |
Ratio P/B pour des entreprises similaires ou concurrentes
| Entreprise | Ratio P/B | Différence de Ratio P/B | Pays |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| 1.3124 | - |
JP
|
|
| 6.3468 | - |
CH
|
|
| 5.041 | - |
IN
|
